These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15385053)

  • 1. Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients.
    Bahnassy AA; Zekri AR; El-Houssini S; El-Shehaby AM; Mahmoud MR; Abdallah S; El-Serafi M
    BMC Gastroenterol; 2004 Sep; 4():22. PubMed ID: 15385053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel immunohistochemical method to estimate cell-cycle phase distribution in archival tissue: implications for the prediction of outcome in colorectal cancer.
    Scott IS; Morris LS; Bird K; Davies RJ; Vowler SL; Rushbrook SM; Marshall AE; Laskey RA; Miller R; Arends MJ; Coleman N
    J Pathol; 2003 Oct; 201(2):187-97. PubMed ID: 14517835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D1 overexpression in primary hypopharyngeal carcinomas.
    Masuda M; Hirakawa N; Nakashima T; Kuratomi Y; Komiyama S
    Cancer; 1996 Aug; 78(3):390-5. PubMed ID: 8697381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of cyclin D1, but not cyclins E and A, is related to progression in bilharzial bladder cancer.
    Osman I; Scher H; Zhang ZF; Soos TJ; Hamza R; Eissa S; Khaled H; Koff A; Cordon-Cardo C
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2247-51. PubMed ID: 9815621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of cell proliferation markers and p53 mutation status on prognosis of non-metastatic colon cancer.
    Demir L; Ekinci N; Erten C; Somali I; Can A; Dirican A; Cokmert S; Bayoglu V; Akyol M; Kucukzeybek Y; Alacacioglu A; Tarhan MO
    J Surg Oncol; 2014 Jun; 109(7):665-75. PubMed ID: 24464927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of tumor markers for proliferation and apoptosis in predicting survival in colorectal cancer.
    Hilska M; Collan YU; O Laine VJ; Kössi J; Hirsimäki P; Laato M; Roberts PJ
    Dis Colon Rectum; 2005 Dec; 48(12):2197-208. PubMed ID: 16400510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymidylate synthase and cyclin D1 protein expression in lymph node negative colorectal cancer: role as prognostic factors?
    Formentini A; Henne-Bruns D; Kornmann M
    Hepatogastroenterology; 2012 Sep; 59(118):1859-64. PubMed ID: 22819905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cell cycle markers in colorectal carcinoma: superiority of cyclin A as an indicator of poor prognosis.
    Handa K; Yamakawa M; Takeda H; Kimura S; Takahashi T
    Int J Cancer; 1999 Jun; 84(3):225-33. PubMed ID: 10371338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
    Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between high initial tissue levels of cyclin d1 and recurrence of nasopharyngeal carcinoma.
    Lai JP; Tong CL; Hong C; Xiao JY; Tao ZD; Zhang Z; Tong WM; Betz CS
    Laryngoscope; 2002 Feb; 112(2):402-8. PubMed ID: 11889405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.
    Namazie A; Alavi S; Olopade OI; Pauletti G; Aghamohammadi N; Aghamohammadi M; Gornbein JA; Calcaterra TC; Slamon DJ; Wang MB; Srivatsan ES
    Laryngoscope; 2002 Mar; 112(3):472-81. PubMed ID: 12148857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue.
    Bova RJ; Quinn DI; Nankervis JS; Cole IE; Sheridan BF; Jensen MJ; Morgan GJ; Hughes CJ; Sutherland RL
    Clin Cancer Res; 1999 Oct; 5(10):2810-9. PubMed ID: 10537346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival.
    Aaltomaa S; Lipponen P; Ala-Opas M; Eskelinen M; Syrjänen K; Kosma VM
    Br J Cancer; 1999 Aug; 80(12):2001-7. PubMed ID: 10471053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53.
    Guo LL; Gao P; Wu YG; Jian WC; Hao CY; Li H; Lin XY
    Arch Med Res; 2007 Nov; 38(8):846-52. PubMed ID: 17923265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of key cell-cycle checkpoint proteins in colorectal tumours.
    McKay JA; Douglas JJ; Ross VG; Curran S; Loane JF; Ahmed FY; Cassidy J; McLeod HL; Murray GI
    J Pathol; 2002 Apr; 196(4):386-93. PubMed ID: 11920733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of p53, p16(INK4a), pRb and Cyclin D1 expression and human papillomavirus in primary ovarian serous carcinomas.
    Bilyk OO; Pande NT; Buchynska LG
    Exp Oncol; 2011 Sep; 33(3):150-6. PubMed ID: 21956468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P21 (WAF1) expression in colorectal cancer: correlation with P53 and cyclin D1 expression, clinicopathological parameters and prognosis.
    Pasz-Walczak G; Kordek R; Faflik M
    Pathol Res Pract; 2001; 197(10):683-9. PubMed ID: 11700890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin d1 is a valuable prognostic marker in oropharyngeal squamous cell carcinoma.
    Yu Z; Weinberger PM; Haffty BG; Sasaki C; Zerillo C; Joe J; Kowalski D; Dziura J; Camp RL; Rimm DL; Psyrri A
    Clin Cancer Res; 2005 Feb; 11(3):1160-6. PubMed ID: 15709184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin alterations in giant cell tumor of bone.
    Kauzman A; Li SQ; Bradley G; Bell RS; Wunder JS; Kandel R
    Mod Pathol; 2003 Mar; 16(3):210-8. PubMed ID: 12640100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.